ReviewTherapeutics and clinical risk management2020

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence.

Silvia Linari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.